Abstract
Myeloid-derived suppressor cells (MDSCs) are immune cells that exert immunosuppression within the tumor, protecting cancer cells from the host’s immune system and/or exogenous immunotherapies. While current research has been mostly focused in countering MDSC-driven immunosuppression, little is known about the mechanisms by which MDSCs disseminate/infiltrate cancerous tissue. This study looks into the use of microtextured surfaces, coupled with in vitro and in vivo cellular and molecular analysis tools, to videoscopically evaluate the dissemination patterns of MDSCs under structurally guided migration, at the single-cell level. MDSCs exhibited topographically driven migration, showing significant intra- and inter-population differences in motility, with velocities reaching ~40 μm h−1. Downstream analyses coupled with single-cell migration uncovered the presence of specific MDSC subpopulations with different degrees of tumor-infiltrating and anti-inflammatory capabilities. Granulocytic MDSCs showed a ~≥3-fold increase in maximum dissemination velocities and traveled distances, and a ~10-fold difference in the expression of pro- and anti-inflammatory markers. Prolonged culture also revealed that purified subpopulations of MDSCs exhibit remarkable plasticity, with homogeneous/sorted subpopulations giving rise to heterogenous cultures that represented the entire hierarchy of MDSC phenotypes within 7 days. These studies point towards the granulocytic subtype as a potential cellular target of interest given their superior dissemination ability and enhanced anti-inflammatory activity.
Similar content being viewed by others
Introduction
The tumor microenvironment is highly heterogeneous in nature, with cancerous cells co-habiting with both stromal and immune cells. Such complex cellular interplay plays a central role in modulating tumor progression. Myeloid-derived suppressor cells (MDSCs), in particular, have been known to exert immunosuppressive activity in the tumor niche, which protects cancerous cells from the host immune system and/or different therapeutic modalities1,2. While a lot of research has been devoted to developing advanced drugs and drug delivery systems to target cancerous cells3,4,5, and/or blocking MDSC-driven immunosuppression within the tumor niche6,7, less is known about the motility mechanisms by which MDSCs disseminate and colonize the tumor in the first place.
MDSCs are innate immune cells that are highly expanded in cancer patients2. These cells tend to infiltrate tumors and lymphoid tissues, and their levels correlate with increased tumor burden and limited survival in a variety of malignancies6,7,8,9. MDSCs specifically contribute to the loss of immune effector cell function and reduce the efficacy of immunotherapies. As such, MDSCs have emerged as an attractive therapeutic target in cancer. Drugs that inhibit MDSC effector functions or proliferation within the tumor could potentially lead to an enhanced host anti-tumor immune response and clearance of the cancer burden. However, efforts to effectively target MDSCs within the tumor niche have been hampered by a lack of robust “druggable” targets at the cellular and/or molecular level. While targeting the dissemination-based mechanisms by which MDSCs infiltrate the tumor niche could be a viable alternative strategy against MDSC-driven immunosuppression at the tumor site, our understanding of such mechanisms for MDSCs is limited compared to what we know about the dissemination modalities of cancerous tumor cells. Structurally guided migration has been known to play a key role in the escape of cancerous cells from the primary tumor, as well as in dissemination and metastasis10,11,12,13,14,15. Nevertheless, to the best of our knowledge, no study has probed MDSC motility under structurally guided dissemination conditions. Here we used microscale engineering tools, coupled with cellular and molecular biology analysis tools, to probe the dissemination capabilities of MDSCs at the single-clone level under guided migration conditions, and to identify MDSC subpopulations of interest based on their disseminative and suppressive capabilities.
Results and Discussion
MDSCs respond to topographical cues and exhibit structurally guided dissemination patterns
Structurally guided cell dissemination has been known to play a role in the escape of cancerous cells from the primary tumor and the establishment of metastatic outgrowths in peripheral organs and tissues. Highly aggressive cancer cells tend to exhibit distinct spreading patterns, disseminating preferentially along pre-aligned anatomical microstructures within the tissues, including radially oriented fibrils from the extracellular matrix (ECM), white matter tracts, the basal lamina of blood vessels, and the subpial/subperitoneal spaces, among others (Fig. 1A)11,16,17. Micro- and nanoscale tools have been used to develop systems that can be utilized to probe cancer cell motility under these physiologically relevant conditions11,17,18,19,20. While topographical or cell confinement cues have been used to mimic rapid and highly directional motility in a wide variety of cancerous cells11,17,18,21,22,23, to the best of our knowledge, no studies have looked into the influence of such cues on the dissemination/infiltration capabilities of tumor-associated MDSCs. Here we tested whether MDSCs respond to topographical cues by exhibiting structurally guided dissemination patterns similar to invasive cancerous cells. The murine MDSC cell line, MSC-2, was used as a model6,24. These cells were plated on microtextured polydimethylsiloxane (PDMS) surfaces (Fig. 1B), which were fabricated via replica molding from photolithographically fabricated silicon masters, and were designed as an array of parallel ridges and grooves with dimensions that have been previously tested in cancer cell dissemination studies (~2 µm × 2 µm with 2 µm spacing)10,11,12,13. MDSC motility was monitored at the single-clone level in real time via time-lapse microscopy. Cells plated on a standard cell culture surface (i.e., tissue culture polystyrene or TCP) were used for comparison purposes. Our results indicate that MDSCs show limited motility at the single-clone level on TCP (Fig. 1C–E) (Video S1), with most cells exhibiting a rounded morphology (Fig. 1C). Textured surfaces, on the other hand, clearly induced cytoskeletal and morphological rearrangements (i.e., alignment) in some of the MDSCs (Fig. 1C), which were conducive to increased motility (Fig. 1D,E) (Video S2). Average single-clone velocities reached a maximum of ~40 μm h−1 on textured surfaces compared to ~20 μm h−1 on TCP. Net track distances, which are a measure of the effective displacement of a single clone, reached a maximum of ~400 μm over a period of 16 hours on textured surfaces compared to <100 μm on TCP. Notably, MDSCs migrating on textured surfaces exhibited significant inter-clonal variability in the dissemination potential, with cells spanning the whole spectrum from low to high motility. In contrast, MDSCs migrating on TCP showed markedly less inter-clonal variability. Studies with circulating MDSCs derived from cancer patients (Fig. S1) further confirmed the existence of highly motile MDSC populations exhibiting marked inter-clonal variability, with some clones showing average guided migration velocities of up to ~200 μm h−1, and total net displacements that approached 1 mm over a period of 16 hours. However, we also found that certain populations of patient-derived circulating MDSCs exhibited limited overall motility, which could potentially be a direct reflection of the underlying malignancy (e.g., type, stage, mutations) and/or concurrent treatment modalities (Tables S1–S3).
MDSC subpopulations exhibit different dissemination capabilities
Based on the clear inter-clonal variability in motility, we proceeded to further stratify and probe the MDSC population via flow cytometry-based sorting into granulocytic (CD11b+Ly6CloLy6G+) and monocytic (CD11b+Ly6ChiLy6G−) subpopulations (Fig. 2A–C) based on standard MDSC nomenclature25. A subpopulation of CD11b+Ly6C+Ly6G+ cells was also identified from the flow cytometry data and included in our analyses. Flow-sorted subpopulations were then subjected to structurally guided motility studies on textured surfaces, as described above, in addition to qRT-PCR analyses of pro- and anti-inflammatory markers. Single-clone dissemination studies indicate that when probed in isolation, granulocytic MDSCs have superior dissemination capabilities compared to monocytic MDSCs and the CD11b+Ly6C+Ly6G+ subpopulation (Fig. 2D) (Videos S3–5), with single clones reaching in some cases average velocities and net displacements of >100 μm h−1 and ~1.5 mm over a period of 16 hours. And while some clones within the monocytic MDSC and CD11b+Ly6C+Ly6G+ subpopulations showed relatively high average migration velocities, ~50 μm h−1, net displacements were considerably limited, thus suggesting that these cells tend to show very short range and/or disorganized motility patterns compared to granulocytic MDSCs (Fig. 2E). These observations were further confirmed via in vivo studies (Fig. 2F,G), where tumor-bearing mice were systemically injected with fluorescently labeled suspensions of sorted vs. “fresh”/unsorted MDSCs, and IVIS was used to document MDSC accumulation within the tumor niche vs. peripheral organs/tissues. The mice that were injected with granulocytic MDSCs showed more pronounced fluorescence signal accumulation within the tumor (Fig. 2G). Parallel single-clone motility studies with circulating MDSCs derived from cancer patients (Fig. S2) also suggest that the granulocytic subpopulation (CD11b+CD15+CD14−) exhibits enhanced motility compared to the monocytic one (CD11b+CD15−CD14+). Gene expression analysis of pro-inflammatory markers indicate no statistically significant differences in the expression of TNF-α, iNOS, and IL-27 between the “fresh” (i.e., unsorted) MDSC population and the purified granulocytic, monocytic, and CD11b+Ly6C+Ly6G+ subpopulations. However, IL-6 was significantly overexpressed in the fresh population vs. the flow-sorted subpopulations. Gene expression analysis of anti-inflammatory markers, on the other hand, suggest that the flow-sorted granulocytic subpopulation has a tendency to overexpress arginase and IL-10 compared to the fresh and flow-sorted monocytic and CD11b+Ly6C+Ly6G+ subpopulations. Altogether, these results suggest that the granulocytic MDSC subpopulation appears to be not only more prone to disseminating and colonizing cancerous tissue, but also to overexpress anti-inflammatory/suppressive markers compared to the monocytic MDSC and the CD11b+Ly6C+Ly6G+ subpopulations.
MDSC subpopulations show phenotypic plasticity that drives populational homeostasis under prolonged culture conditions
Following flow-based purification of the MSC-2 cells into distinct subpopulations of granulocytic and monocytic MDSCs, as well as CD11b+Ly6C+Ly6G+ cells, the cells were maintained in culture for 1–7 days. Phenotypic plasticity was evaluated via flow cytometry at days 1 and 7. Single-clone motility assays and gene expression analyses were run at day 7 (Fig. 3A). Surprisingly, and in contrast to what we found immediately after flow-based sorting; no significant differences were detected in the dissemination characteristics across all three populations by day 7 (Fig. 3B). Average single-clone velocities stayed within ~50 μm h−1 for all populations, while the overall net track distance stayed below ~200 μm. Flow cytometry analyses indicated that 1 day post-sorting the purified populations still comprised the majority (~80%) of the culture, however, by day 7 the whole hierarchy of populations had been reestablished (Fig. 3C–E), possibly suggesting a role for cellular plasticity in the maintenance of populational homeostasis/heterogeneity in MDSC populations. Cell cultures derived from the purified granulocytic subpopulation (Fig. 3C), for example, gave rise to monocytic MDSCs and CD11b+Ly6C+Ly6G+ cells, with the monocytic subpopulation showing the sharpest increase from day 1 to 7 (~7-fold change), and the CD11b+Ly6C+Ly6G+ population showing a ~3-fold increase by day 7. Cultures derived from purified monocytic MDSCs, on the other hand, were more prone to giving rise to the CD11b+Ly6C+Ly6G+ population by day 7 (~2.5-fold increase) compared to the granulocytic population. Finally, cultures derived from the purified CD11b+Ly6C+Ly6G+ population were more prone to giving rise to granulocytic MDSCs by day 7 (~3-fold increase) compared to the monocytic MDSCs, which did not show a significant increase between days 1 and 7. Gene expression profiles of pro- (Fig. 3F) and anti-inflammatory (Fig. 3G) markers at day 7 showed more subtle differences across populations, with decreased and increased iNOS and IL-6 expression, respectively, in the “fresh” MDSC population relative to the sorted/purified subpopulations. However, when comparing the expression profiles between day 0 (i.e., day of sorting/purification) and day 7, a more pronounced difference was noted, with an overall increase in the expression of pro-inflammatory iNOS for all three populations, and a significant decrease in arginase1 and Il-10 for the granulocytic subpopulation only (Fig. S3).
Conclusions
Micro- and nanoscale technologies have been used extensively to probe and/or modulate various aspects of cell biology for medical applications10,11,12,13,14,15,26,27,28,29,30,31,32,33,34,35,36, especially in cancer therapy and diagnostics3,37,38,39,40,41,42. Here we used microscale engineering tools to demonstrate that tumor-associated MDSCs exhibit structurally guided migration patterns, similar to invasive cancerous cells. Single-clone motility analyses unmasked clear heterogeneities within and across (i.e., for patient-derived MDSCs) MDSC populations, confirming the presence of clonal subsets with enhanced dissemination capabilities in both murine and patient-derived MDSCs. Follow-up motility studies coupled with flow cytometry-based sorting, gene expression analyses, and orthotopic tumor xenograft experiments in nude mice, suggest that the granulocytic subpopulation is more prone to exhibiting increased dissemination and tumor-infiltrative ability, as well as enhanced anti-inflammatory activity, which could make this population an attractive cellular target in cancer research and therapeutic development. Subsequent studies, however, highlight the remarkably dynamic and plastic nature of such clonal subsets, with purified MDSC subpopulations quickly reaching populational homeostasis by giving rise to the full spectrum of MDSC phenotypes. While there have been conflicting reports regarding the dominant phenotype of tumor-resident MDSCs (i.e., granulocytic vs. monocytic)43,44,45,46,47, our single-clone dissemination and phenotypic plasticity results point towards a potential mechanism by which granulocytic MDSCs are presumably better equipped to infiltrate the tumor niche, where they could then remain as granulocytic and/or give raise to monocytic MDSCs depending on multiple factors, including the tumor type. Interestingly, single-clone dissemination studies with circulating MDSCs derived from cancer patients suggest that MDSC motility could potentially be impacted by the patient’s background (e.g., type/stage of cancer, treatment modalities, etc.), and as such, additional studies are needed to determine whether the dissemination patterns of circulating MDSCs, ex vivo, could be used to monitor disease and/or treatment progression.
Materials and Methods
Textured PDMS surfaces
Microtextured PDMS surfaces were fabricated from photolithographically patterned silicon masters via a replica molding process. A parallel array of ridges and grooves (2 µm wide, 2 µm tall, spaced by 2 µm) was first patterned on a silicon master via standard UV photolithography using S1813 photoresist. A 10:1 mixture of PDMS with curing agent was then cast on the master and allowed de-gas and cure for several hours. The PDMS was then demolded from the master, sterilized and placed on multi-well plates for single-cell migration experiments. Scanning electron microscopy (SEM) was used to characterize the surface morphology.
MDSC cultures
The mouse MDSC cell line (MSC-2) was a kind donation from Gregoire Mignot. MSC-2 cells were cultured in RPMI 1640 media supplemented with 25 mM HEPES, 10% heat-inactivated fetal bovine serum (FBS), 1% antibiotic-antimycotic, and 1 mM sodium pyruvate. Patient-derived MDSCs were enriched from peripheral blood using the RosetteSep HLA-myeloid cell enrichment kit (Stemcell Technologies) followed by Ficoll-Paque centrifugation (GE healthcare). MDSC were isolated by subsequent negative selection of HLA-DRneg cells using anti-HLA-DR MicroBeads (Miltenyi Biotec) for 15 minutes at 4 °C and isolated using a MS-MACS column. Patient-derived MDSCs were acquired with informed consent under institutional review board (IRB)-approved protocols for human subject research at The Ohio State University, in accordance with the Declaration of Helsinki.
Single-cell migration assays
~1.5 × 105 MSC-2 cells were seeded and allowed to adhere on the textured PDMS surfaces or TCP controls in regular culture media for several hours. Cells were imaged via time-lapse microscopy every 10 minutes for over 16 h using a cell culture chamber (Okolab) mounted on an inverted microscope. Images were analyzed using the manual tracker plugin in Fiji. Single-cell displacement data were then analyzed via MATLAB to determine velocities and net track traveled distances.
Flow cytometry-based analysis and sorting
The following antibodies were used for the MSC-2 cells: anti-CD11b-FITC, anti-Ly6-C-APC and anti-Ly6-G-PE, all purchased from Biolegend. For patient-derived MDSCs, we used anti-CD33-APC, anti-CD11b-AP, and anti-HLA-DR-PECy7, purchased from Beckman Coulter. Data were acquired using an LSRII flow cytometer (BD Biosciences). All colors were evaluated against their respective isotype controls and samples with no staining.
Gene expression analyses
Total RNA was extracted using the TRizol reagent (ThermoFisher). Reverse transcription reactions were performed using 500–1000 ng RNA in a 20 μl reaction with the superscript VILO cDNA synthesis kit (ThermoFisher). cDNA was used as a template to measure the expression levels of pro- and anti-inflammatory genes by quantitative real-time PCR using predesigned primers. Real-time PCR reactions were performed using the QuantStudio 3 Real-Time PCR System with TaqMan fast advance chemistry (Thermo Scientific) with the following conditions: 95 °C 10 min, 40 cycles of 95 °C 1 min, 60 °C 1 min, and 72 °C 1 min. Gene expression was normalized against the house keeping genes GAPDH and ATP-6.
Orthotopic tumor xenografts
Immunodeficient nude mice (Jackson Laboratory), 6–8-week-old, were first injected with 1 million human breast cancer cells (MDA-MB-231, ATCC) in the mammary fat pad to generate tumors. After 4 weeks of tumor development, sorted MDSC subpopulations were stained using PKH67 green fluorescent cell linker kit for general cell membrane labeling (Millipore Sigma) following the instructions suggested by the manufacturer. Tumor-bearing mice were then injected with ~2.5 × 105 MDSCs via the tail vein. The mice were then collected 1-day post-injection, and the tumors, lungs and spleens were characterized with an IVIS Imaging System (Xenogen Imaging Technologies). All animal studies were performed in accordance with protocols approved by the Laboratory Animal Care and Use Committee of The Ohio State University.
Statistical analysis
All statistical analyses were run in Sigma Plot 12 or GraphPad Prism 7. We used n = 3–6 replicates per experiment. Specific information on the number replicates, statistical tests, and levels of significance can be found in the figure legends.
Data availability
The data generated through this study are available from the corresponding author upon reasonable request.
References
Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860 (2002).
Wesolowski, R., Markowitz, J. & Carson, W. E. Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer. J Immunother Cancer 1, 10, https://doi.org/10.1186/2051-1426-1-10 (2013).
Qiu, M. et al. Novel concept of the smart NIR-light–controlled drug release of black phosphorus nanostructure for cancer therapy. Proceedings of the National Academy of Sciences 115, 501–506 (2018).
Qiu, M. et al. Biocompatible and biodegradable inorganic nanostructures for nanomedicine: Silicon and black phosphorus. Nano Today (2019).
Luo, M., Fan, T., Zhou, Y., Zhang, H. & Mei, L. 2D Black Phosphorus–Based Biomedical Applications. Advanced Functional Materials 29, 1808306 (2019).
Stiff, A. et al. Myeloid-derived suppressor cells express Bruton’s tyrosine kinase and can be depleted in tumor bearing hosts by ibrutinib treatment. Cancer Res 76, 2125–2136, https://doi.org/10.1158/0008-5472.CAN-15-1490 (2016).
Dubovsky, J. A. et al. Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood 122, 2539–2549, https://doi.org/10.1182/blood-2013-06-507947 (2013).
Stiff, A., et al MDSC inhibit FcR-mediated natural killer cell function via nitric oxide. Nitric Oxide Production by Myeloid Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function. Clin CA Res In Press (2018).
Mundy-Bosse, B. L. et al. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res 71, 5101–5110, https://doi.org/10.1158/0008-5472.CAN-10-2670 (2011).
Gallego-Perez, D. et al. On-Chip Clonal Analysis of Glioma-Stem-Cell Motility and Therapy Resistance. Nano Lett 16, 5326–5332, https://doi.org/10.1021/acs.nanolett.6b00902 (2016).
Gallego-Perez, D. et al. Microfabricated mimics of in vivo structural cues for the study of guided tumor cell migration. Lab Chip 12, 4424–4432, https://doi.org/10.1039/c2lc40726d (2012).
Kim, S. H. et al. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-kappaB-dependent Manner. Cancer Cell 29, 201–213, https://doi.org/10.1016/j.ccell.2016.01.005 (2016).
Gu, S. Q. et al. The human PMR1 endonuclease stimulates cell motility by down regulating miR-200 family microRNAs. Nucleic Acids Res 44, 5811–5819, https://doi.org/10.1093/nar/gkw497 (2016).
Minata, M. et al. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. Cell reports 26, 1893–1905. e1897 (2019).
Shukla, V. C. et al. Lab-on-a-chip platforms for biophysical studies of cancer with single-cell resolution. Trends in biotechnology 36, 549–561 (2018).
Bellail, A. C., Hunter, S. B., Brat, D. J., Tan, C. & Van Meir, E. G. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36, 1046–1069, https://doi.org/10.1016/j.biocel.2004.01.013 (2004).
Johnson, J. et al. Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy. Tissue Eng Part C Methods 15, 531–540, https://doi.org/10.1089/ten.TEC.2008.0486 (2009).
Irimia, D. & Toner, M. Spontaneous migration of cancer cells under conditions of mechanical confinement. Integr Biol (Camb) 1, 506–512, https://doi.org/10.1039/b908595e (2009).
Doyle, A. D., Wang, F. W., Matsumoto, K. & Yamada, K. M. One-dimensional topography underlies three-dimensional fibrillar cell migration. J Cell Biol 184, 481–490, https://doi.org/10.1083/jcb.200810041 (2009).
Petrie, R. J., Doyle, A. D. & Yamada, K. M. Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10, 538–549, https://doi.org/10.1038/nrm2729 (2009).
Sidani, M., Wyckoff, J., Xue, C., Segall, J. E. & Condeelis, J. Probing the microenvironment of mammary tumors using multiphoton microscopy. J Mammary Gland Biol Neoplasia 11, 151–163, https://doi.org/10.1007/s10911-006-9021-5 (2006).
Provenzano, P. P. et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 4, 38, https://doi.org/10.1186/1741-7015-4-38 (2006).
Wong, I. Y. et al. Collective and individual migration following the epithelial-mesenchymal transition. Nat Mater 13, 1063–1071, https://doi.org/10.1038/nmat4062 (2014).
Trikha, P. et al. Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator. Oncoimmunology 5, e1214787 (2016).
Bronte, V. et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7, 12150, https://doi.org/10.1038/ncomms12150 (2016).
Benavente-Babace, A. et al. Single-cell trapping and selective treatment via co-flow within a microfluidic platform. Biosens Bioelectron 61, 298–305, https://doi.org/10.1016/j.bios.2014.05.036 (2014).
Fei, Z. et al. Gene delivery to cultured embryonic stem cells using nanofiber-based sandwich electroporation. Analytical chemistry 85, 1401–1407 (2013).
Chang, L. et al. Controllable Large-Scale Transfection of Primary Mammalian Cardiomyocytes on a Nanochannel Array Platform. Small 12, 5971–5980, https://doi.org/10.1002/smll.201601465 (2016).
Chang, L. et al. Dielectrophoresis-assisted 3D nanoelectroporation for non-viral cell transfection in adoptive immunotherapy. Lab Chip 15, 3147–3153, https://doi.org/10.1039/c5lc00553a (2015).
Gallego-Perez, D. et al. Micro/nanoscale technologies for the development of hormone-expressing islet-like cell clusters. Biomed Microdevices 14, 779–789, https://doi.org/10.1007/s10544-012-9657-4 (2012).
Gallego-Perez, D. et al. Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers. Nanomedicine 12, 399–409, https://doi.org/10.1016/j.nano.2015.11.015 (2016).
Gallego-Perez, D. et al. Topical tissue nano-transfection mediates non-viral stroma reprogramming and rescue. Nature nanotechnology 12, 974 (2017).
Wu, Y. et al. Surface-mediated nucleic acid delivery by lipoplexes prepared in microwell arrays. Small 9, 2358–2367, https://doi.org/10.1002/smll.201202258 (2013).
Zhao, X. et al. Nanochannel Electroporation as a Platform for Living Cell Interrogation in Acute Myeloid Leukemia. Advanced Science 2, n/a–n/a, https://doi.org/10.1002/advs.201500111 (2015).
Zhao, X. et al. Effect of nonendocytic uptake of nanoparticles on human bronchial epithelial cells. Anal Chem 87, 3208–3215, https://doi.org/10.1021/ac503366w (2015).
Tao, W. et al. Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications. Chemical Society Reviews (2019).
Xue, T. et al. Ultrasensitive detection of miRNA with an antimonene-based surface plasmon resonance sensor. Nature communications 10, 28 (2019).
Ji, X. et al. A Novel Top-Down Synthesis of Ultrathin 2D Boron Nanosheets for Multimodal Imaging-Guided Cancer Therapy. Advanced Materials 30, 1803031 (2018).
Xing, C. et al. Two-dimensional MXene (Ti3C2)-integrated cellulose hydrogels: toward smart three-dimensional network nanoplatforms exhibiting light-induced swelling and bimodal photothermal/chemotherapy anticancer activity. ACS applied materials & interfaces 10, 27631–27643 (2018).
Tao, W. et al. Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics. Advanced materials 30, 1802061 (2018).
Fan, T., Zhou, Y., Qiu, M. & Zhang, H. Black phosphorus: A novel nanoplatform with potential in the field of bio-photonic nanomedicine. Journal of Innovative Optical Health Sciences 11, 1830003 (2018).
Fan, T., Xie, Z., Huang, W., Li, Z. & Zhang, H. Two-dimensional non-layered selenium nanoflakes: facile fabrications and applications for self-powered photo-detector. Nanotechnology (2019).
Kumar, V., Patel, S., Tcyganov, E. & Gabrilovich, D. I. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends in immunology 37, 208–220 (2016).
Hossain, F. et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer immunology research 3, 1236–1247 (2015).
Haverkamp, J. M., Crist, S. A., Elzey, B. D., Cimen, C. & Ratliff, T. L. In vivo suppressive function of myeloid*derived suppressor cells is limited to the inflammatory site. European journal of immunology 41, 749–759 (2011).
Mairhofer, D. G. et al. Impaired gp100-Specific CD8+ T-cell responses in the presence of myeloid-derived suppressor cells in a spontaneous mouse melanoma model. Journal of Investigative Dermatology 135, 2785–2793 (2015).
Bozkus, C. C., Elzey, B. D., Crist, S. A., Ellies, L. G. & Ratliff, T. L. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell–Mediated Control of T Cell Immunity. The Journal of Immunology 195, 5237–5250 (2015).
Acknowledgements
Funding was partly provided by NINDS/NIH (R21NS099869), NIBIB/NIH (DP2EB028110), and AHA (18PRE34070054). The MSC-2 cells were a kind donation from Gregoire Mignot to the lab of William E. Carson (OSU). Some of the illustrations were created with BioRender.com.
Author information
Authors and Affiliations
Contributions
S.D.-S., W.E.C. and D.G.-P. conceived the idea. S.D.-S., V.S., B.B., J.M., G.G.-V., N.H.-C., N.I. and S.G. were involved in microtexture fabrication, characterization, cell migration experiments and analyses. S.D.-S., L.L., A.P. and S.W., contributed with qRT-PCR characterization. S.D.-S., A.P. and W.L. were in charge of in vivo experiments. D.G.-P. prepared the manuscript with input from S.D.-S., W.E.C., B.B. and S.G.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Duarte-Sanmiguel, S., Shukla, V., Benner, B. et al. Guided migration analyses at the single-clone level uncover cellular targets of interest in tumor-associated myeloid-derived suppressor cell populations. Sci Rep 10, 1189 (2020). https://doi.org/10.1038/s41598-020-57941-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-020-57941-8
- Springer Nature Limited